Advertisement

High-Resolution Melt Curve Analysis in Cancer Mutation Screen

Protocol
  • 3.4k Downloads
Part of the Methods in Molecular Biology book series (MIMB, volume 1392)

Abstract

High-resolution melt (HRM) curve analysis is a PCR-based assay that identifies sequence alterations based on subtle variations in the melting curves of mutated versus wild-type DNA sequences. HRM analysis is a high-throughput, sensitive, and efficient alternative to Sanger sequencing and is used to assess for mutations in clinically important genes involved in cancer diagnosis. The technique involves PCR amplification of a target sequence in the presence of a fluorescent double-stranded DNA (dsDNA) binding dye, melting of the fluorescent amplicons, and subsequent interpretation of melt curve profiles.

Key words

High-resolution melt curve analysis PCR Double-stranded DNA binding fluorescent dyes 

References

  1. 1.
    Nguyen-Dumont T, Calvez-Kelm FL, Forey N et al (2009) Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis. Hum Mutat 30:884–890PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Erali M, Voelkerding KV, Wittwer CT (2008) High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol 85:50–58PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Vossen RH, Aten E, Roos A et al (2009) High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 30:860–866CrossRefPubMedGoogle Scholar
  4. 4.
    Montgomery J, Wittwer CT, Palais R et al (2007) Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis. Nat Protoc 2:59–66CrossRefPubMedGoogle Scholar
  5. 5.
    Smith BL, Lu CP, Alvarado Bremer JR (2010) High-resolution melting analysis (HRMA): a highly sensitive inexpensive genotyping alternative for population studies. Mol Ecol Resour 10:193–196CrossRefPubMedGoogle Scholar
  6. 6.
    Wittwer CT (2009) High-resolution DNA melting analysis: advancements and limitations. Hum Mutat 30:857–859CrossRefPubMedGoogle Scholar
  7. 7.
    Patel KP, Barkoh BA, Chen Z et al (2011) Diagnostic testing for IDH1 and IDH2 variants in acute myeloid leukemia an algorithmic approach using high-resolution melting curve analysis. J Mol Diagn 13:678–686PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Singh RR, Bains A, Patel KP et al (2012) Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysis. J Mol Diagn 14:336–345CrossRefPubMedGoogle Scholar
  9. 9.
    Cammenga J, Horn S, Bergholz U et al (2005) Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate. Blood 106:3958–3961CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of HematopathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations